Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    21041705 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting A Pilot Study of Alemtuzumab (Campath[R]) in Patients With Myelodysplastic Syndrome
Condition: Myelodysplastic Syndromes
Intervention: Drug: Alemtuzumab (Campath)

Study has passed its completion date and status has not been verified in more than two years.